Author: Henry Miller

This year's influenza ("flu") season, which has already begun in some parts of the country, revs up in November, and last until spring, will be made more ominous than ever by the current high numbers of COVID-19 cases in many parts of the nation. The coincidence of infections in the population by the two highly infectious respiratory viruses has the potential to create a "twindemic" for our already stressed healthcare infrastructure. As of October 7th, daily cases of COVID-19 nationally were...

After more than a year and a half of an agonizing pandemic, researchers at Merck and Ridgeback Biotherapeutics have announced a successful oral antiviral treatment. The drug, called molnupiravir, prevents about half of COVID-19-associated hospitalizations. The data monitoring committee, which oversees clinical trials, stopped the trials because the evidence of efficacy was sufficiently persuasive — hospitalizations reduced by 50%, deaths by 100% — that they deemed it unethical to continue with a placebo-treated control group. On Oct. 11, the sponsors requested emergency...

Dr. Henry Miller talks to the nationally-syndicated Lars Larson Show based out of Oregon about innovations in artificially constructed organs and tissue that could be used to make up for the shortage of organ transplants. Miller also talks about the use of genetically-engineered animals, and the regulatory issues with the FDA, to develop organs for transplant into humans. Lars Larson National Podcast · Lars Larson National Podcast 09-28-21...

Modern medicine has produced many kinds of high-tech miracles, among them gene therapy to correct malfunctioning genes, electrical stimulation devices to restore significant function after traumatic spinal cord injury, and surgery performed by robots. Another medical area that desperately needs breakthroughs is transplantation of solid organs. We are making progress but are not quite there. Currently, donor organs — from a living donor or cadaver — must match the recipient's tissue type and size, and often, they are not perfect. By one estimate, approximately half of...

Dr. Henry Miller joined the John Batchelor show to talk about new study out of Israel analyzing the efficacy and infection rate of new booster shots for COVID-19. Miller breaks down the findings, noting that the booster group fared better than a control group who didn't receive the booster, the latest on mask mandates, and also looks at the data around the performance of the various vaccines against COVID variants. Miller is a senior fellow with PRI and former FDA...

By Henry Miller, M.S., M.D. and John J. Cohrssen President Joe Biden’s recent Executive Order 14036 contains initiatives intended to lower drug prices for patients, create more competition to increase wages for workers, promote innovation, and foster economic growth. As part of it, on Sept. 9 Health and Human Services Secretary Xavier Becerra proposed additional legislative and administrative actions. The drug price-reduction legislative proposals are perennials; their inclusion reflects both their popularity and the difficulty in attaining them. Two executive order proposals – one to import cheaper...

There is continuing confusion, and even consternation, over what seem to be disparate policies, recommendations and mandates emerging in response to the Delta-driven surge of COVID-19 infections and hospitalizations in much of the country. Masks or no masks? Vaccine mandates versus voluntary vaccination? Proof of vaccination for admission to bars and entertainment venues? The Zeitgeist is nicely captured by this Saturday Night Live sketch earlier this summer on the CDC’s seemingly ever-changing mask policy: In fact, the patchwork of policies and what some have derided as “moving the...

Given the abundance of readily available, free, effective (albeit imperfect) vaccines for many months, why are we seeing a surge in COVID cases and hospitalizations? Let's examine the three primary factors that dictate the severity of an outbreak of a viral illness. The United States is in the throes of a surge of serious infections with the COVID-19 Delta variant. The seven-day average of COVID-19 new admissions to hospitals nationwide has exceeded 11,000 for the past few weeks, overwhelming healthcare capacity...

The United States is not coping well with the current surge of COVID-19 infections. Coronavirus-related hospitalizations nationwide surpassed 100,000 last week for only the second time in the pandemic, overwhelming caregiver capacity in several states. The worst situation is in intensive care units , which care for the sickest patients with highly specialized medical staff who are in short supply and are becoming progressively burned out as the pandemic drags on. The result is that in many parts of the country, patients needing to be...

The study of genetics has always been an attempt to understand our biologically determined fate. Many of us know of families with a predisposition to maladies like heart disease or breast cancer. There are many kinds of interventions that can modulate the effects of our genetic endowment, whether directly (as in highly sophisticated gene therapy for genetic diseases) or pharmaceutical treatments, such as human growth hormone for growth hormone deficiency. But even when such targeted interventions aren't possible, we can modulate...

Dr. Henry Miller joins the nationally-syndicated Lars Larson Show to discuss the "swiss cheese" approach to testing, screening, and treating COVID-19 and the impact to civil liberties. Miller and Larson debate the balance needed to react to COVID-19 and the moving target by public health officials. Lars Larson National Podcast · Lars Larson National Podcast 08-03-21...

Each of the measures shown in the figure here--the "Swiss cheese model of prevention"--lowers the probability that an infectious dose of virus will find its way to your respiratory tract and, if it does, will actually cause an infection. Also, depending on the effectiveness and extent of vaccine administration, vaccination could make some of the other interventions superfluous. Such strategies are the essence of preventive medicine. Many of us take drugs to lower our cholesterol levels or blood pressure to reduce the...

Dr. Henry Miller joins the John Batchelor Show to discuss the FDA's footdragging on COVID-19 vaccines for continued use and the nuances of what the emergency use declarations mean. Miller talks about the data behind full vaccine approval and what it would take for the FDA to issue a final approval. ...

It's been about six months since the Food and Drug Administration allowed the distribution of the first COVID-19 vaccines via emergency use authorizations, which are preliminary approvals during a public health emergency based on lower standards of safety and efficacy than for a normal, or "full," approval. As of July 13, 48.1% of the U.S. population had been fully vaccinated. However, uptake has been inconsistent among different groups and locales, the earlier momentum for vaccination has waned, and there are surges of...

The myth about endangered, disappearing honeybees lives on — with potentially dire implications. Rep. Earl Blumenauer, an Oregon Democrat, just reintroduced “Save the Bees” legislation that would eliminate farmers’ most advanced and effective defenses against crop-destroying pests in the name of preventing imaginary bee declines and preserving food security, which the bill would actually undermine. According to Blumenauer’s press release, “The United States lost an estimated one-third of its honeybee colonies between 2016 and 2018.” This sounds scary, except the Department of...

Dr. Henry Miller talks about potential life-saving medical technology with organ transplants on the nationally-syndicated Lars Larson Show. Dr. Miller talks about advances in 3-D printing for liver, gallbladder, and even heart transplants and why the FDA is slow to test and approve these groundbreaking practices. Dr. Miller's segment begins at the 48-minute mark. Lars Larson National Podcast · Lars Larson National Podcast 06-22-21...